Article
An Innovative antibody-based Plug-and-Play strategy for SARS-CoV-2
2021-03-12
Abstract excerpt
The novel and highly pathogenic coronavirus (SARS-CoV-2) remains a public health threat worldwide. SARS-CoV-2 enters human host lung cells via its spike protein binding to angiotensin-converting enzyme 2 (ACE2) in a process critical dependent on host protease-mediated fusion event. Thus, effective targeted therapies blocking the first step of viral fusion and cellular entry remains a critical unmet medical need to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8abc0109-4866-519e-b213-9ac3ecf0f812
- DOI
- 10.1101/2021.03.11.434589
